CellGenix, a manufacturer of GMP-grade raw materials for cell therapy, gene therapy, and tissue-engineered products, has completed the first phase of its headquarters expansion, the company announced on June 21, 2018. The expansion is in response to customer demand, which is expected to increasOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.